S9: Nonclinical Evaluation for Anticancer Pharmaceuticals

Regulatory Resource: S9: Nonclinical Evaluation for Anticancer Pharmaceuticals

Description:

This guideline has been released for consultation under Step 2 of the ICH process on 13 November 2008.
This guideline provides information for pharmaceuticals that are only intended to treat cancer in patients with late stage or advanced disease regardless of the route of administration, including both small molecule and biotechnology-derived pharmaceuticals. It describes the type and timing of nonclinical studies in relation to the development of anticancer pharmaceuticals and references other guidance as appropriate.

Download Document: S9: Nonclinical Evaluation for Anticancer Pharmaceuticals

0.12 Megabytes